BAROLDI JOSEPH (Chief Business Officer) sold 10.8% of their position (5.62K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $419.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/17/2026ACC: 0000874015-26-000169
Officer· Chief Business Officer
Since Jan 2022
-5.62K
Net shares
Net seller
$419.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.84K acquired · 16.46K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.84K
Price / share
—
Trade value
—
% of position
26.2%
4/15/2026
41.32K→52.15K
Common Stock
Direct
Shares
−5.62K
Price / share
$74.56
Trade value
$418.95K
% of position
10.8%
4/16/2026
52.15K→46.53K
Total
Net shares
+5.22K
Net value
-$418.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | M · Option Exercise | +10.84K | — | — | 26.2% | 41.32K | 52.15K |
| Common Stock Direct | 4/16/2026 | S · Sale | −5.62K | $74.56 | $418.95K | 10.8% | 52.15K | 46.53K |
| Total | +5.22K | -$418.95K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
10.84K shares
Shares
−10.84K
Strike price
0.0
Held after
48.31K
Exercisable
—
4/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock10.84K shares | 4/15/2026 | M · Option Exercise | −10.84K | 0.0 | — | 48.31K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.35K
Total
4.35K indirect4.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.35K | Indirect |
| Total | 4.35K | 4.35K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported